These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1148 related items for PubMed ID: 3142911

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
    Ley SB, Leonard JM.
    J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
    [Abstract] [Full Text] [Related]

  • 4. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
    Büchter D, Behre HM, Kliesch S, Nieschlag E.
    Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
    [Abstract] [Full Text] [Related]

  • 5. Comparison of pulsatile subcutaneous gonadotropin-releasing hormone and exogenous gonadotropins in the treatment of men with isolated hypogonadotropic hypogonadism.
    Liu L, Chaudhari N, Corle D, Sherins RJ.
    Fertil Steril; 1988 Feb; 49(2):302-8. PubMed ID: 3123278
    [Abstract] [Full Text] [Related]

  • 6. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
    Schaison G, Young J, Pholsena M, Nahoul K, Couzinet B.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
    [Abstract] [Full Text] [Related]

  • 7. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z, Wang X, Yu B, Ma W, Zhang P, Wu X, Nie M, Mao J.
    Arch Endocrinol Metab; 2024 May 10; 68():e230101. PubMed ID: 38739523
    [Abstract] [Full Text] [Related]

  • 8. Gonadotropin therapy in men with isolated hypogonadotropic hypogonadism: the response to human chorionic gonadotropin is predicted by initial testicular size.
    Burris AS, Rodbard HW, Winters SJ, Sherins RJ.
    J Clin Endocrinol Metab; 1988 Jun 10; 66(6):1144-51. PubMed ID: 3372679
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of spermatogenesis in hypogonadotropic hypogonadal men with human chorionic gonadotropin alone.
    Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E.
    Eur J Endocrinol; 2002 Nov 10; 147(5):617-24. PubMed ID: 12444893
    [Abstract] [Full Text] [Related]

  • 10. Optimal treatment for spermatogenesis in male patients with hypogonadotropic hypogonadism.
    Lin J, Mao J, Wang X, Ma W, Hao M, Wu X.
    Medicine (Baltimore); 2019 Aug 10; 98(31):e16616. PubMed ID: 31374027
    [Abstract] [Full Text] [Related]

  • 11. Pulsatile gonadotropin-releasing hormone treatment of men with idiopathic hypogonadotropic hypogonadism.
    Christiansen P, Skakkebaek NE.
    Horm Res; 2002 Aug 10; 57(1-2):32-6. PubMed ID: 12006717
    [Abstract] [Full Text] [Related]

  • 12. Induction of puberty in a patient with hypogonadotropic hypogonadism: effect of sequentially applied hCG and pulsatile GnRH administration.
    Klingmüller D, Menger D, Wildt L, Leyendecker G, Krück F, Schweikert HU.
    Horm Metab Res; 1985 Jul 10; 17(7):358-61. PubMed ID: 3928472
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Stimulation of serum inhibin concentrations by gonadotropin-releasing hormone in men with idiopathic hypogonadotropic hypogonadism.
    Sheckter CB, McLachlan RI, Tenover JS, Matsumoto AM, Burger HG, de Kretser DM, Bremner WJ.
    J Clin Endocrinol Metab; 1988 Dec 10; 67(6):1221-4. PubMed ID: 3142917
    [Abstract] [Full Text] [Related]

  • 15. Induction of testicular growth and spermatogenesis by pulsatile, intravenous administration of gonadotrophin-releasing hormone in patients with hypogonadotrophic hypogonadism.
    Delemarre-Van de Waal HA.
    Clin Endocrinol (Oxf); 1993 May 10; 38(5):473-80. PubMed ID: 8330443
    [Abstract] [Full Text] [Related]

  • 16. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
    Huang B, Mao J, Xu H, Wang X, Liu Z, Nie M, Wu X.
    Zhonghua Yi Xue Za Zhi; 2015 May 26; 95(20):1568-71. PubMed ID: 26463603
    [Abstract] [Full Text] [Related]

  • 17. Hypogonadotropic hypogonadism in severe beta-thalassemia: effect of chelation and pulsatile gonadotropin-releasing hormone therapy.
    Wang C, Tso SC, Todd D.
    J Clin Endocrinol Metab; 1989 Mar 26; 68(3):511-6. PubMed ID: 2493034
    [Abstract] [Full Text] [Related]

  • 18. Pulsatile gonadotropin secretion after discontinuation of long term gonadotropin-releasing hormone (GnRH) administration in a subset of GnRH-deficient men.
    Finkelstein JS, Spratt DI, O'Dea LS, Whitcomb RW, Klibanski A, Schoenfeld DA, Crowley WF.
    J Clin Endocrinol Metab; 1989 Aug 26; 69(2):377-85. PubMed ID: 2502554
    [Abstract] [Full Text] [Related]

  • 19. Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications.
    McLachlan RI, Finkel DM, Bremner WJ, Snyder PJ.
    J Clin Endocrinol Metab; 1990 May 26; 70(5):1414-9. PubMed ID: 2110576
    [Abstract] [Full Text] [Related]

  • 20. Pulsatile gonadotrophin releasing hormone versus gonadotrophin treatment of hypothalamic hypogonadism in males.
    Schopohl J.
    Hum Reprod; 1993 Nov 26; 8 Suppl 2():175-9. PubMed ID: 8276954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.